“…1,2 Unfortunately, overlapping imaging patterns are not uncommon, such as when urothelial carcinoma presents as a predominantly parenchymal mass 3 or renal cell carcinoma extends into the renal pelvis. 4 The usefulness of CK7 and CK20 in determining the primary site of a carcinoma has been documented for several clinical settings, including lung versus colon, uterus versus colon, and metastatic carcinoma presenting in the liver. [5][6][7][8][9][10][11] The unique CK profiles of carcinomas from various primary sites make these powerful tools, and our results show that CK7 and CK20 coexpression is a useful test to confirm urothelial origin and to rule out renal cell carcinoma in patients with renal masses.…”